Evgeniy Kovalchuk

Statistics

Publications

Citations

275

H-Index

Active since

2020

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Evgeniy Kovalchuk is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, transient ischemic attack prevention, and medicine.

Publications per year

2020–2025

Publications

Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin

Pierre Amarenco, Hans Denison, Scott Evans et al. · Stroke · 2020 · 100 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults

Yoseph Caraco, Gordon Crofoot, Pablo Andrés Moncada et al. · NEJM Evidence · 2021 · 99 citations

Medicine, Infectious Diseases, Pharmacology +14

Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke

Pierre Amarenco, Hans Denison, Scott Evans et al. · JAMA Neurology · 2020 · 44 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 32 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

1–4 of 4